Press Releases Intervacc AB

Equities

IVACC

SE0009607252

Market Closed - Nasdaq Stockholm Other stock markets 06:59:52 2024-04-30 am EDT			5-day change	1st Jan Change
4.205 ^SEK	+0.72%		+4.99%	-33.57%

Mar. 04	Intervacc AB Announces Changes in the Nomination Committee	CI
Feb. 28	Intervacc's Acting CEO Assumes Role Permanently	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Notice of Annual General Meeting in Intervacc AB (publ)	Apr. 15	AQ
Intervacc publishes the 2023 Annual Report	Apr. 10	AQ
Intervacc announces changes in the Nomination Committee	Mar. 04	AQ
Jonas Sohlman appointed as new CEO for Intervacc	Feb. 28	AQ
Intervacc announces changes in dates for AGM and report for the first quarter 2024	Feb. 22	AQ
Year-end report January - December 2023	Feb. 16	AQ
Invitation to conference call and audiocast in connection with the year-end report	Feb. 13	AQ
Intervacc awarded prestigious Eurostars grant to advance their new prototype vaccine against Streptococcus suis infection in pigs	Feb. 07	AQ
Intervacc announces changes in the Nomination Committee	Dec. 21	AQ
The National Equestrian Centre at Flyinge to host European expert meeting on the use of vaccination to prevent strangles in horses	Dec. 11	AQ
Report from Extraordinary General Meeting in Intervacc	Nov. 23	AQ
U.S. patent approval for Intervacc's vaccine against infections caused by Streptococcus suis	Nov. 22	AQ
Interim report January - September 2023	Nov. 16	AQ
Invitation to conference call with presentation of Intervacc's Interim report for the third quarter, 2023	Nov. 15	AQ
Nomination Committee appointed in Intervacc	23-10-30	AQ
NOTICE OF EXTRAORDINARY GENERAL MEETING IN INTERVACC AB (PUBL)	23-10-19	AQ
Intervacc : Agneta Gustafsson joins Intervacc	23-09-12	PU
Andreas Andersson steps down as President and CEO. Jonas Sohlman has been appointed acting President and CEO for Intervacc	23-08-21	AQ
Intervacc awarded grant to optimise production processes for a fusion protein, which is one component of a prototype vaccine for pigs	23-08-17	AQ
Intervacc to collaborate with Testa Center to optimise production processes for their prototype vaccine for pigs	23-07-11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Intervacc AB

Equities

IVACC

SE0009607252

Press Releases

Filters